MOUNTAIN VIEW, Calif., May 11 /PRNewswire/ -- Aviron (Nasdaq: AVIR) today
announced that Alan C. Mendelson has been elected to the company's board of
directors, effective immediately.
Mr. Mendelson is a senior partner in the Menlo Park office of
Latham & Watkins, a major global law firm. In addition to serving as Aviron's
corporate secretary since 1992, Mr. Mendelson also serves on the board of
directors of Axys Pharmaceuticals Inc., iScribe Inc., Isis Pharmaceuticals
Inc. and US SEARCH.com Inc. Twice, Mr. Mendelson has been recognized as one of
America's 100 most influential lawyers by the National Law Journal.
Mr. Mendelson holds a bachelor's degree from the University of California at
Berkeley and a J.D. from the Harvard Law School.
"Alan's knowledge of the biotechnology industry, his legal expertise and
sound business judgment provide additional strength to Aviron's board," said
C. Boyd Clarke, Aviron president and chief executive officer.
Mr. Mendelson replaces Jane E. Shaw, Ph.D. on the board of directors.
Charlene Friedman, Aviron vice president and general counsel, is the new
corporate secretary.
Aviron is a biopharmaceutical company based in Mountain View, California,
focused on the prevention of disease through innovative vaccine technology.
Actual results may differ materially from the forward-looking statements
contained in this release. Factors that could cause actual results to differ
include, but are not limited to, failure to validate the manufacturing
process, facilities or equipment for the company's nasal influenza vaccine,
and the assessment by regulatory agencies that the company's future license
applications for its nasal influenza vaccine are incomplete or inadequate to
approve the product for marketing to one or more target populations.
Additional information concerning factors that could cause such a difference
is contained in Aviron's SEC filings, including its Annual Report on Form 10-K
for the year ended December 31, 1999.
To receive an index and copies of recent press releases, call Aviron's
News-On-Call toll-free fax service, 800-758-5804, ext. 114000. Additional
information about the company can be located at http://www.aviron.com .
SOURCE Aviron
 back to top
Related links:
http://www.aviron.com
Company News On-Call:
http://www.prnewswire.com/comp/114000.html or fax,
800-758-5804, ext. 114000
CONTACT:
media or investors, John Bluth, 650-919-3716,
or investors, Fred Kurland, 650-919-6666, both of Aviron; or
media, Claudette Hibbert of Fleishman-Hillard, 212-453-2000, for
Aviron
|
